Present-Day Locoregional Control in Patients with T1 or T2 Breast Cancer with 0 and 1 to 3 Positive Lymph Nodes After Mastectomy Without Radiotherapy
- 5 May 2010
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 17 (11), 2899-2908
- https://doi.org/10.1245/s10434-010-1089-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20Journal of Clinical Oncology, 2010
- Predicting the Risk of Axillary Nodal Metastases and Their Use in Selecting Breast Surgery OptionsJournal of Clinical Oncology, 2009
- Radiation Therapy and Breast Reconstruction: A Critical Review of the LiteraturePlastic and Reconstructive Surgery, 2009
- Ten-Year Recurrence Rates in Young Women With Breast Cancer by Locoregional Treatment ApproachInternational Journal of Radiation Oncology*Biology*Physics, 2008
- Estrogen Receptor, Progesterone Receptor, HER-2, and Response to Postmastectomy Radiotherapy in High-Risk Breast Cancer: The Danish Breast Cancer Cooperative GroupJournal of Clinical Oncology, 2008
- Advances and surgical decision‐making for breast reconstructionCancer, 2006
- Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized TrialJNCI Journal of the National Cancer Institute, 2005
- Patterns of Locoregional Failure in Patients With Operable Breast Cancer Treated by Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical TrialsJournal of Clinical Oncology, 2004
- Postmastectomy Radiation Therapy: Who Needs It?Journal of Clinical Oncology, 2004
- Risk Factors for Locoregional Recurrence Among Breast Cancer Patients: Results From International Breast Cancer Study Group Trials I Through VIIJournal of Clinical Oncology, 2003